Search

Displaying results 6981 - 6990 of 8468 in total
  1. Drug

    DDP-225

    go.drugbank.com/drugs/DB05642
    Investigational

    DDP225 is both a noradrenaline reuptake inhibitor and a serotonin type 3 receptor (5-HT3) antagonist. Noradrenaline and serotonin are neurotransmitters that are known to be involved in the control of the gastrointestinal system. The uniq...

  2. Drug

    Nicaraven

    go.drugbank.com/drugs/DB06397
    Experimental

  3. Drug

    DP-VPA

    go.drugbank.com/drugs/DB05821
    Investigational

    DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure

  4. Drug

    Trodusquemine

    go.drugbank.com/drugs/DB06333
    Investigational

    It has demonstrated the ability to stimulate regeneration of heart and multiple other tissues in animal models [A176600].

  5. Drug

    2'-fluoro-5-ethylarabinosyluracil

    go.drugbank.com/drugs/DB13030
    Investigational

    2'-fluoro-5-ethylarabinosyluracil (FAU) has been used in trials studying the treatment of Small Intestine Lymphoma, Stage IV Mantle Cell Lymphoma, Waldenström Macroglobulinemia, Splenic Marginal Zone Lymphoma

  6. Drug

    CDX-1135

    go.drugbank.com/drugs/DB17607
    Investigational

    It was investigated in clinical trials for post-cardiopulmonary bypass syndrome and kidney damage.

  7. Drug

    Detirelix

    go.drugbank.com/drugs/DB19488
    Experimental

    Detirelix has a monoisotopic molecular weight of 1536.78 Da.

  8. Drug

    Terdecamycin

    go.drugbank.com/drugs/DB19720
    Experimental

    Terdecamycin has a monoisotopic molecular weight of 585.31 Da.

  9. Drug

    Stallimycin

    go.drugbank.com/drugs/DB20261
    Experimental

    Stallimycin has a monoisotopic molecular weight of 481.22 Da.

  10. Drug

    Sornidipine

    go.drugbank.com/drugs/DB21432
    Experimental

    Sornidipine has a monoisotopic molecular weight of 460.15 Da.